Showing results (41-50 of 174) with videos related to
Sort By:
Pageof 18
The Journal of Antimicrobial Chemotherapy|July 31, 2023
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and cliniciansAliaa Fouad, Christian M Gill, Patricia J Simner, et al.Infection and Immunity|December 19, 2018
The Obligate Intracellular Bacterium Orientia tsutsugamushi Targets NLRC5 To Modulate the Major Histocompatibility Complex Class I PathwayKyle G Rodino, Haley E Adcox, Rebecca K Martin, et al.Clinical Chemistry|December 30, 2021
Recent Advances in Rapid Antimicrobial Susceptibility TestingRucha Datar, Sylvain Orenga, Romain Pogorelcnik, et al.Open Forum Infectious Diseases|April 22, 2022
Geographic Variation of Infectious Disease Diagnoses Among Patients With Fever of Unknown Origin: A Systematic Review and Meta-analysisWilliam F Wright, Gayane Yenokyan, Patricia J Simner, et al.Journal of Clinical Microbiology|August 30, 2013
Detection and identification of yeasts from formalin-fixed, paraffin-embedded tissue by use of PCR-electrospray ionization mass spectrometryPatricia J Simner, Seanne P Buckwalter, James R Uhl, et al.Journal of Clinical Microbiology|June 17, 2025
Point-Counterpoint: Cascade reporting-useful tool to support antimicrobial stewardship, or dangerously misleadingJoseph L Kuti, Joseph D Lutgring, Patricia J Simner, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2012
Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infectionsEmily L Heil, Lindsay M Daniels, Dustin M Long, et al.Microbial Drug Resistance (Larchmont, N.Y.)|October 7, 2021
Defining Baseline Mechanisms of Cefiderocol Resistance in the EnterobacteralesPatricia J Simner, Stephan Beisken, Yehudit Bergman, et al.Antimicrobial Agents and Chemotherapy|August 19, 2024
Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilliLili Tao, Ashley Dahlquist, Harley Harris, et al.Open Forum Infectious Diseases|July 15, 2021
Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam ResistancePatricia J Simner, Stephan Beisken, Yehudit Bergman, et al.Pageof 18